hexamethonium has been researched along with Disease in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
RAFSKY, HA | 1 |
HORONICK, A | 1 |
RAFSKY, JC | 1 |
PHELAN, EL | 1 |
ERYETISHIR, I | 1 |
SMIRK, FH | 1 |
2 other studies available for hexamethonium and Disease
Article | Year |
---|---|
Treatment of hypertension in elderly patients with methium chloride; preliminary report.
Topics: Aged; Cardiovascular Agents; Disease; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central | 1953 |
Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium.
Topics: Arginine Vasopressin; Disease; Epinephrine; Hexamethonium; Hypertension; Rats; Rodent Diseases; Thio | 1962 |